Quantification of minimal residual disease in chronic lymphocytic leukemia (CLL) following hematopoietic stem cell transplant

Stem Cell Transplant ◽

Residual Disease ◽

Lymphocytic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Minimal Residual Disease Analysis and its Impact after Hematopoietic Stem Cell Transplant for Acute Leukemias

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.07.035 ◽

2017 ◽

Vol 17 ◽

pp. S266

Author(s):

Caroline Bernardi ◽

Aruana Legnani ◽

Vaneuza Funke ◽

Daniela Setubal ◽

Michel Oliveira ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Residual Disease ◽

Cell Transplant ◽

Acute Leukemias ◽

Hematopoietic Stem ◽

Disease Analysis ◽

Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2016.10.009 ◽

2016 ◽

Vol 29 (4) ◽

pp. 345-350 ◽

Cited By ~ 9

Author(s):

Mark R. Litzow

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Residual Disease ◽

Philadelphia Chromosome ◽

Cell Transplant ◽

Hematopoietic Stem ◽

First Remission ◽

Invasive Pulmonary Nocardiosis With Extrapulmonary Joint Extension After Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia

CHEST Journal ◽

10.1378/chest.2268489 ◽

2015 ◽

Vol 148 (4) ◽

pp. 155A

Author(s):

Lauren Lee ◽

Dana Blyth ◽

Thomas Raj ◽

Charles Borders ◽

Samantha Butler ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphocytic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Pulmonary Nocardiosis

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Leukemia & Lymphoma ◽

10.3109/10428194.2012.666661 ◽

2012 ◽

Vol 53 (9) ◽

pp. 1699-1705 ◽

Cited By ~ 9

Author(s):

Maciej Machaczka ◽

Jan-Erik Johansson ◽

Mats Remberger ◽

Helene Hallböök ◽

Claes Malm ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Lymphocytic Leukemia ◽

Cell Transplant ◽

Reduced Intensity Conditioning ◽

Hematopoietic Stem ◽

Cell Engraftment ◽

Reduced Intensity

Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-0199 ◽

2009 ◽

Vol 15 (14) ◽

pp. 4759-4768 ◽

Cited By ~ 29

Author(s):

Tetsuya Nishida ◽

Michael Hudecek ◽

Ana Kostic ◽

Marie Bleakley ◽

Edus H. Warren ◽

...

Keyword(s):

T Cells ◽

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphocytic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem

Allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia in the era of novel agents: Challenges, pitfalls and strengths

Oncology Signaling ◽

10.1016/j.onsig.2018.09.004 ◽

2018 ◽

Vol 1 (1) ◽

pp. 14-16

Author(s):

Cynthia L. Toze ◽

Steven Huang

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphocytic Leukemia ◽

Novel Agents ◽

Cell Transplant ◽

Hematopoietic Stem

Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission

Cancers ◽

10.3390/cancers4020601 ◽

2012 ◽

Vol 4 (2) ◽

pp. 601-617 ◽

Cited By ~ 8

Author(s):

Rada M. Grubovikj ◽

Asif Alavi ◽

Ahrin Koppel ◽

Mary Territo ◽

Gary J. Schiller

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Stem Cell Transplant ◽

Residual Disease ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Minimal Residual ◽

Acute Myeloid

Successful Treatment of Richter's Transformation with Ibrutinib in Patient with Chronic Lymphocytic Leukemia (CLL) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.12.431 ◽

2017 ◽

Vol 23 (3) ◽

pp. S267

Author(s):

Samip Master ◽

Cheri Leary ◽

Amy Bozeman ◽

Breanne Peyton-Thomas ◽

Srinivas Devarakonda ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Successful Treatment ◽

Stem Cell Transplant ◽

Lymphocytic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Richter's Transformation

A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Case Medical Research ◽

10.31525/ct1-nct03901963 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Treatment ◽

Stem Cell Transplant ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed ◽

Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicentric trial

Haematologica ◽

10.3324/haematol.2019.239566 ◽

2020 ◽

pp. haematol.2019.239566

Author(s):

Olivier Tournilhac ◽

Magali Le Garff-Tavernier ◽

Stéphanie Nguyen Quoc ◽

Edouard Forcade ◽

Patrice Chevallier ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Residual Disease ◽

Lymphocytic Leukemia ◽

Immune Intervention ◽

Hematopoietic Stem ◽